EFFECTIVENESS AND SAFETY OF PEMBROLIZUMAB IN ADVANCED OR METASTATIC MELANOMA: PRELIMINARY RESULTS FROM REAL WORLD

被引：0
|
作者：
Cardoso Borges, F. [1 ]
Murteira, R. [2 ]
Ramos, C. [1 ]
Soares, P. [1 ]
Ferreira, M. [3 ]
Furtado, C. [4 ]
Miranda, A. [1 ]
Alves da Costa, F. [1 ]
机构：
[1] Portuguese Oncol Inst Lisbon Francisco Gentil IPO, Natl Oncol Registry RON, Lisbon, Portugal
[2] Portuguese Oncol Inst Lisbon Francisco Gentil IPO, Natl Oncol Registry RON, Cascais 11, Portugal
[3] Portuguese Oncol Inst Lisbon Francisco Gentil IPO, Oncol Dept, Lisbon, Portugal
[4] Natl Author Med & Hlth Prod, IP INFARMED, Lisbon, Portugal
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN2
引用
收藏
页码：S15 / S15
页数：1
相关论文
共 50 条
  • [1] "REAL WORLD" PEMBROLIZUMAB IN METASTATIC MELANOMA
    Flynn, Alexandra E.
    Day, Fiona L.
    Geyde, Craig A.
    van der Westhuizen, Andre
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 122 - 122
  • [2] Preliminary cladribine effectiveness and safety results: real world data
    Ubago Perez, R.
    Alvarez Sanchez, R.
    Nieto Gomez, P.
    Portillo Haro, S.
    Cabeza Barrera, J.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2020, 42 (01) : 284 - 285
  • [3] REAL WORLD EXPOSURE SURVIVAL RELATIONSHIP OF PEMBROLIZUMAB IN METASTATIC MELANOMA
    Navani, Vishal
    Graves, Moira
    Marchett, Giovana
    Mandaliya, Hiren
    Bowden, Nikola
    Van der Westhuizen, Andre
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A144 - A145
  • [4] Real-world effectiveness of pembrolizumab in advanced melanoma: analysis of a French national clinicobiological database
    Casarotto, Emilie
    Chandwani, Sheenu
    Mortier, Laurent
    Dereure, Olivier
    Dutriaux, Caroline
    Dalac, Sophie
    Scherrer, Emilie
    Levy-Bachelot, Laurie
    Verdoni, Laetitia
    Farge, Gaelle
    Allayous, Clara
    Oriano, Bastien
    Dalle, Stephane
    Lebbe, Celeste
    IMMUNOTHERAPY, 2021, 13 (11) : 905 - 916
  • [5] The safety of pembrolizumab in metastatic melanoma and rheumatoid arthritis
    Puri, Akshjot
    Homsi, Jade
    MELANOMA RESEARCH, 2017, 27 (05) : 519 - 523
  • [6] COST EFFECTIVENESS OF PEMBROLIZUMAB AND IPILIMUMAB IN ADVANCED MELANOMA
    Lu, T.
    Hay, J. W.
    VALUE IN HEALTH, 2016, 19 (03) : A149 - A149
  • [7] Efficacy and safety of combined treatment with pembrolizumab in patients with locally advanced or metastatic esophageal squamous cell carcinoma in the real world
    Zhang, Pei
    Hou, Xiaobin
    Cai, Boning
    Yu, Wei
    Chen, Jing
    Huang, Xiang
    Li, Ye
    Zeng, Mingyue
    Ren, Zhipeng
    Gabriel, Emmanuel
    Qu, Baolin
    Liu, Fang
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (12)
  • [8] Preliminary safety and efficacy data from a phase 1/2 study of epacadostat (INCB024360) in combination with pembrolizumab in patients with advanced/metastatic melanoma
    Gajewski, Thomas F.
    Hamid, Omid
    Smith, David C.
    Bauer, Todd M.
    Wasser, Jeffrey S.
    Luke, Jason J.
    Balmanoukian, Ani S.
    Kaufman, David R.
    Zhao, Yufan
    Maleski, Janet
    Leopold, Lance
    Gangadhar, Tara C.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14
  • [9] EFFECTIVENESS AND SAFETY OF VEMURAFENIB AS MONOTHERAPY IN UNRESECTABLE OR METASTATIC MELANOMA FROM AN ACADEMIC DATABASE: REAL WORLD DATA TO STRENGTHEN EVIDENCE FOR PAYER
    Borget, I
    Dalle, S.
    Leccia, M.
    Dutriaux, C.
    Stoebner, P.
    Dalac, S.
    Aubin, F.
    Saiag, P.
    Lacour, J. P.
    Lesimple, T.
    Dupuy, A.
    Mortier, L.
    Beylot-Barry, M.
    Maubec, E.
    Descamps, V
    Lok, C.
    Stephan, A.
    Guillot, B.
    de Quatrebarbes, J.
    Dreno, B.
    Gally, S.
    Mouri, M.
    Allayous, C.
    Kowal, A.
    Porcher, R.
    Lebbe, C.
    VALUE IN HEALTH, 2016, 19 (07) : A762 - A763
  • [10] EFFECTIVENESS AND SAFETY OF PEMBROLIZUMAB IN ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
    Murteira, R.
    Ramos, C.
    Cardoso Borges, F.
    Ferreira, M. M.
    Miranda, A.
    da Costa, Alves F.
    VALUE IN HEALTH, 2018, 21 : S15 - S15
12345